Advanced NanoTherapies Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$31M
- Investors
-
7
Advanced NanoTherapies General Information
Description
Developer of a biodegradable functionalized nanoparticle technology designed for cardiovascular and endovascular applications. The company creates technologies focusing on cardiovascular and endovascular applications that improve drug uptake and retention into the cell for medical devices, enabling clinicians to offer a safer therapeutic option to peripheral artery disease patients.
Contact Information
Website
www.advancednanotherapies.comCorporate Office
- 2903 Bunker Hill Lane
- Suite 150
- Santa Clara, CA 95054
- United States
Corporate Office
- 2903 Bunker Hill Lane
- Suite 150
- Santa Clara, CA 95054
- United States
Advanced NanoTherapies Timeline
Advanced NanoTherapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 02-Jan-2026 | $31M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series A) | 22-Aug-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 13-Oct-2020 | $5.3M | $5.3M | Completed | Generating Revenue |
Advanced NanoTherapies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 5,357,250 | $0.000020 | $1.49 | $1.49 | 1x | $1.49 | 26.67% | |
| Seed | 4,371,500 | $0.000020 | $1.12 | $1.12 | 1x | $1.12 | 21.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Advanced NanoTherapies Patents
Advanced NanoTherapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4469128-A1 | Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith | Pending | 28-Jan-2022 | ||
| EP-4469128-A4 | Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith | Pending | 28-Jan-2022 | ||
| GB-2630714-A | Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith | Pending | 28-Jan-2022 | ||
| US-20250114577-A1 | Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith | Pending | 28-Jan-2022 | ||
| WO-2023147102-A1 | Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith | Inactive | 28-Jan-2022 | A61M25/10184 |
Advanced NanoTherapies Signals
Advanced NanoTherapies Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| S3 Ventures | Venture Capital | Minority | ||
| BE Capital | Corporation | Minority | ||
| Kinled Holding | Family Office | Minority | ||
| T45 Labs | Accelerator/Incubator | Minority | ||
| TK & Partners | Venture Capital | Minority |
Advanced NanoTherapies FAQs
-
When was Advanced NanoTherapies founded?
Advanced NanoTherapies was founded in 2018.
-
Where is Advanced NanoTherapies headquartered?
Advanced NanoTherapies is headquartered in Santa Clara, CA.
-
What is the size of Advanced NanoTherapies?
Advanced NanoTherapies has 10 total employees.
-
What industry is Advanced NanoTherapies in?
Advanced NanoTherapies’s primary industry is Drug Delivery.
-
Is Advanced NanoTherapies a private or public company?
Advanced NanoTherapies is a Private company.
-
What is Advanced NanoTherapies’s current revenue?
The current revenue for Advanced NanoTherapies is .
-
How much funding has Advanced NanoTherapies raised over time?
Advanced NanoTherapies has raised $50.2M.
-
Who are Advanced NanoTherapies’s investors?
S3 Ventures, BE Capital, Kinled Holding, T45 Labs, and TK & Partners are 5 of 7 investors who have invested in Advanced NanoTherapies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process